INFORMATION ON THIS SITE IS ONLY INTENDED FOR NON-US HEALTHCARE PROFESSIONALS

Welcome to Novo Nordisk at ESPE 2021

We're glad you're here! Explore and get inspired: initiatives, developments, and solutions curated for you.

Read below for commercial content, information, and resources.

Norditropin® for children with Noonan syndrome

Norditropin® is the only growth hormone treatment indicated for growth failure due to Noonan syndrome.

Learn More

Weight management for the next generation

Managing weight goes beyond a number on a scale. Explore how Saxenda® not only helps patients manage weight but also improve their health.

Learn More

Our Norditropin® devices

Meeting patients' needs: Learn about our prefilled and preloaded FlexPro® and NordiFlex® pens, PenMate® option, and read about our commitment to the environment.

Explore

Norditropin® - 30 years of commitment

The #1 prescribed growth hormone treatment with over 30 years of commitment to growth disorders.

Watch the video

FOR HEALTHCARE PROFESSIONALS ONLY The information contained in this site is intended for healthcare professionals only. This site is not intended to provide medical advice and/or treatment guidance. This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site. By accessing this site and materials you accept this legal notice. SmPC The Summary of Product Characteristics (SmPC) is based on the EU SmPC of May 2021. Registration conditions differ from country to country. Always refer to the full local SmPC before prescribing Norditropin®. Norditropin is registered in EU, USA, Canada, Latin America, Middle East and Asia.

 

 

Read below for disease awareness content.

Watch today and support ICOSEP.

Now Screening: Patient Perspectives on Growth Disorders

Small for Gestational Age (SGA)

Watch Emerence, a dynamic 18-year-old, discuss the day-to-day impact that being born SGA has had on her life.

Watch now

Noonan Syndrome

Hear from Colton and his mother as they offer compelling insight into the lives of children with Noonan syndrome.

Watch now

Related content

It's MoreThanHeight, it's health!

This engaging, friendly website offers information and resources for parents of children with growth disorders.

Explore

Rethink Obesity® Educational Website

Talking about obesity with your patients can be difficult, as weight can be a sensitive issue. Explore resources to support your patients and optimise obesity management.

Visit Rethink Obesity® Website

Explore the resources below for scientific content.

  1. Visit the Novo Nordisk Rare Diseases Science Hub

    Here you will find useful resources relating to the science presented at the congress as well as a searchable database of Novo Nordisk scientific materials on Rare Disorders. The site is intended for HCPs and is provided for the purpose of scientific exchange.